Shandong Pharmaceutical Glass Co.Ltd (SHA: 600529)
China flag China · Delayed Price · Currency is CNY
25.89
+0.01 (0.04%)
Nov 13, 2024, 3:00 PM CST

Shandong Pharmaceutical Glass Co.Ltd Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
17,18116,98918,84726,11929,83816,445
Upgrade
Market Cap Growth
4.56%-9.86%-27.84%-12.46%81.44%103.66%
Upgrade
Enterprise Value
14,38714,57118,19525,06228,53314,931
Upgrade
Last Close Price
25.8924.9227.3441.7947.2825.92
Upgrade
PE Ratio
19.4621.3026.5442.2149.7733.66
Upgrade
PS Ratio
3.343.414.506.748.715.50
Upgrade
PB Ratio
2.212.252.715.597.014.25
Upgrade
P/FCF Ratio
28.8145.13-41.13-444.07968.412233.32
Upgrade
P/OCF Ratio
17.0516.2174.6634.8152.7227.45
Upgrade
EV/Sales Ratio
2.802.924.356.478.334.99
Upgrade
EV/EBITDA Ratio
10.6412.4218.9927.2732.4521.46
Upgrade
EV/EBIT Ratio
14.3117.1727.4536.9443.1428.34
Upgrade
EV/FCF Ratio
24.1338.71-39.70-426.11926.062027.68
Upgrade
Debt / Equity Ratio
-0.000.00---
Upgrade
Debt / EBITDA Ratio
-0.000.01---
Upgrade
Debt / FCF Ratio
-0.00-0.01---
Upgrade
Asset Turnover
0.540.550.550.640.640.61
Upgrade
Inventory Turnover
3.083.202.963.433.303.11
Upgrade
Quick Ratio
2.232.542.271.431.771.78
Upgrade
Current Ratio
2.863.213.021.992.412.40
Upgrade
Return on Equity (ROE)
11.63%10.70%10.63%13.24%13.90%12.41%
Upgrade
Return on Assets (ROA)
6.61%5.86%5.45%7.05%7.66%6.72%
Upgrade
Return on Capital (ROIC)
8.28%7.31%7.12%9.50%10.18%8.91%
Upgrade
Earnings Yield
5.14%4.57%3.28%2.26%1.89%2.79%
Upgrade
FCF Yield
3.47%2.22%-2.43%-0.23%0.10%0.04%
Upgrade
Dividend Yield
2.32%1.61%1.10%0.72%0.63%1.16%
Upgrade
Payout Ratio
30.10%25.66%28.87%30.20%31.62%27.80%
Upgrade
Buyback Yield / Dilution
-1.74%-10.46%-0.54%-0.49%0.26%0.22%
Upgrade
Total Shareholder Return
0.58%-8.86%0.56%0.23%0.89%1.38%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.